Browse Studies — Arctuva

Phase 2

Sensory Phenotyping to Enhance Neuropathic Pain Drug Development (SPENDD): A Randomized, Double-blinded Cross-over Clinical Trial Aimed at Investigating Whether Bedside Quantitative Sensory Testing Can Predict Response to Analgesics.

The goal of this clinical trial is to determine whether quantitative sensory testing (QST) can be used to classify participants into pain sub-groups and predic…

Painful Peripheral NeuropathyDiabetic Peripheral Neuropathic Pain (DPN)Chemotherapy Induced Peripheral Neuropathy (CIPN)+1 more

Estimated

~$10 – $6,250

University of RochesterNCT06614322

Observational

Feasibility of Self-Applied Vagus Nerve Stimulation for Chemotherapy Induced Peripheral Neuropathy

The purpose of this study is to determine the feasibility of using a portable device at home to self-administer transcutaneous auricular vagus nerve stimulatio…

Chemotherapy Induced Peripheral Neuropathy

Estimated

~$10 – $6,250

University of MiamiNCT07596030

Observational

IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study

Chemotherapy drugs, used in the treatment of cancer, have the potential of inducing peripheral neuropathy (PN) as a side effect. This side effect is commonly r…

Chemotherapy Induced Peripheral Neuropathy (CIPN)

Estimated

~$10 – $8,750

Luminate Medical, Inc.NCT07142304

Observational and Data Collection Study About Intrathecal Ziconotide in the Treatment of Chemotherapy Induced Neuropathy

The purpose of this observational, data collection, research is to evaluate if ziconotide, a commercially approved medication given by a FDA cleared intratheca…

Chemotherapy Induced Peripheral Neuropathy (CIPN)

Estimated

~$10 – $750

Christian Hospital Northeast NorthwestNCT07499882